Muscle Recovery & Repair — Peptide Research Overview
Skeletal muscle repair after injury, intense training, or surgery depends on satellite cell activation, protein synthesis, and reduction of inflammatory signaling. Several peptide compounds have been studied for their ability to accelerate this process, reduce recovery time, and preserve lean mass during periods of reduced activity.
Relevant Compounds
- TB-500 — Thymosin Beta-4 fragment; studied for systemic tissue repair and muscle cell migration.
- BPC-157 — Shown to accelerate healing of muscle tears and reduce inflammatory damage in exercise models.
- IGF-1 LR3 — Long Arg3 IGF-1; a potent activator of satellite cells and muscle protein synthesis with extended half-life vs. native IGF-1.
What the Research Shows
TB-500
[Animal Study / Preliminary] TB-500 promotes actin upregulation, enabling myocyte migration to damaged tissue. Rodent studies show accelerated healing of cardiac and skeletal muscle. The systemic distribution makes it effective for diffuse or hard-to-reach injury sites. No large-scale human trials exist, but veterinary use (equine sports medicine) is well-documented.
BPC-157
[Animal Study] BPC-157 has been shown to accelerate recovery from muscle crush injuries and surgical transection in rodent models. Proposed mechanisms include modulation of growth hormone receptors, promotion of angiogenesis at injury sites, and reduction of local oxidative stress. Stacking with TB-500 (the "Wolverine Stack") is commonly described in research communities for synergistic effect.
IGF-1 LR3
[Animal Study / Preliminary] IGF-1 LR3 binds IGF-1 receptors with high affinity and resists degradation by IGF binding proteins, giving it a half-life of approximately 20–30 hours vs. 20 minutes for native IGF-1. In animal models, it drives satellite cell proliferation and differentiation, leading to increased muscle fiber cross-sectional area. Human data is limited to small observational series and case reports in bodybuilding/research contexts.
Evidence Summary
| Compound | Evidence Level | Primary Mechanism |
|---|---|---|
| TB-500 | Animal / Preliminary | Actin upregulation, myocyte migration, systemic repair |
| BPC-157 | Animal / Preliminary Human | GH receptor modulation, angiogenesis, oxidative stress reduction |
| IGF-1 LR3 | Animal / Preliminary | Satellite cell activation, protein synthesis, extended IGF-1 signaling |
Research Disclaimer
No compound listed on this page is FDA-approved for muscle recovery or repair. This page is an educational summary of existing research. Consult your healthcare provider before using any peptide or experimental compound.
Track your compounds with Dosi
Log doses, monitor symptoms, and build a personal health timeline. Free to start.
Start Tracking Free →Educational use only. This content is for informational purposes only and does not constitute medical advice. Individual results vary. Always consult a licensed healthcare provider before starting any compound.